Articles by B. G Nordestgaard (7)

Context-Dependent Associations Between Variation in Risk of Ischemic Heart Disease and Variation in the 5' Promoter Region of the Apolipoprotein E Gene in Danish Women

J. H Stengard, G Dyson, R Frikke Schmidt, A Tybjaerg Hansen, B. G Nordestgaard and C. F. Sing

Circulation: Cardiovascular Genetics 3 ( 1 ): 22 - 30 , 2010

Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein: Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)

P. M Ridker, F. A.H Fonseca, J Genest, A. M Gotto, J. J.P Kastelein, W Koenig, P Libby, A. J Lorenzatti, B. G Nordestgaard, J Shepherd, J. T Willerson, R. J Glynn and for the JUPITER Study Group

Circulation: Cardiovascular Quality and Outcomes 2 ( 6 ): 616 - 623 , 2009

Rosuvastatin for Primary Prevention Among Individuals With Elevated High-Sensitivity C-Reactive Protein and 5% to 10% and 10% to 20% 10-Year Risk: Implications of the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial for "Intermediate Risk"

P. M Ridker, J. G MacFadyen, B. G Nordestgaard, W Koenig, J. J. P Kastelein, J Genest and R. J. Glynn

Circulation: Cardiovascular Quality and Outcomes 3 ( 5 ): 447 - 452 , 2010

Risk Factors for Near-Term Myocardial Infarction in Apparently Healthy Men and Women

B. G Nordestgaard, A. S Adourian, J. J Freiberg, Y Guo, P Muntendam and E. Falk

Clinical Chemistry 56 ( 4 ): 559 - 567 , 2010

High Pre-{beta}1 HDL Concentrations and Low Lecithin: Cholesterol Acyltransferase Activities Are Strong Positive Risk Markers for Ischemic Heart Disease and Independent of HDL-Cholesterol

A. A Sethi, M Sampson, R Warnick, N Muniz, B Vaisman, B. G Nordestgaard, A Tybjaerg Hansen and A. T. Remaley

Clinical Chemistry 56 ( 7 ): 1128 - 1137 , 2010

Lipoprotein(a) and Risk of Type 2 Diabetes

S Mora, P. R Kamstrup, N Rifai, B. G Nordestgaard, J. E Buring and P. M. Ridker

Clinical Chemistry 56 ( 8 ): 1252 - 1260 , 2010

Risk of Estrogen Receptor-Positive and -Negative Breast Cancer and Single-Nucleotide Polymorphism 2q35-rs13387042

R. L Milne, J Benitez, H Nevanlinna, T Heikkinen, K Aittomaki, C Blomqvist, J. I Arias, M. P Zamora, B Burwinkel, C. R Bartram, A Meindl, R. K Schmutzler, A Cox, I Brock, G Elliott, M. W. R Reed, M. C Southey, L Smith, A. B Spurdle, J. L Hopper, F. J Couch, J. E Olson, X Wang, Z Fredericksen, P Schurmann, M Bremer, P Hillemanns, T Dork, P Devilee, C. J van Asperen, R. A. E. M Tollenaar, C Seynaeve, P Hall, K Czene, J Liu, Y Li, S Ahmed, A. M Dunning, M Maranian, P. D. P Pharoah, G Chenevix Trench, J Beesley, kConFab Investigators, N. N Antonenkova, I. V Zalutsky, H Anton Culver, A Ziogas, H Brauch, C Justenhoven, Y. D Ko, S Haas, P. A Fasching, R Strick, A. B Ekici, M. W Beckmann, G. G Giles, G Severi, L Baglietto, D. R English, O Fletcher, N Johnson, I dos Santos Silva, J Peto, C Turnbull, S Hines, A Renwick, N Rahman, B. G Nordestgaard, S. E Bojesen, H Flyger, D Kang, K. Y Yoo, D. Y Noh, A Mannermaa, V Kataja, V. M Kosma, M Garcia Closas, S Chanock, J Lissowska, L. A Brinton, J Chang Claude, S Wang Gohrke, C. Y Shen, H. C Wang, J. C Yu, S. T Chen, M Bermisheva, T Nikolaeva, E Khusnutdinova, M. K Humphreys, J Morrison, R Platte, D. F Easton and on behalf of the Breast Cancer Association Consortium

JNCI J Natl Cancer Inst 101 ( 14 ): 1012 - 1018 , 2009